362 related articles for article (PubMed ID: 33178336)
1. COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study.
Crolley VE; Hanna D; Joharatnam-Hogan N; Chopra N; Bamac E; Desai M; Lam YC; Dipro S; Kanani R; Benson J; Wilson W; Fox TA; Shiu KK; Forster M; Bridgewater J; Hochhauser D; Khan K
Ther Adv Med Oncol; 2020; 12():1758835920971147. PubMed ID: 33178336
[TBL] [Abstract][Full Text] [Related]
2. Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.
Di Cosimo S; Tagliaferri B; Generali D; Giudici F; Agustoni F; Bernardo A; Borgonovo K; Farina G; Luchena G; Luciani A; Nolè F; Palmeri L; Pietrantonio F; Poggi G; Zucali PA; Balletti E; Catania G; Bernocchi O; D'Antonio F; Giordano M; Grossi F; Lasagna A; La Verde N; Manzoni M; Montagna B; Olgiati A; Raimondi A; Rampinelli I; Verri E; Zaniboni A; Di Maio M; Beretta G; Danova M
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809465
[TBL] [Abstract][Full Text] [Related]
3. The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre.
Russell B; Moss C; Tsotra E; Gousis C; Josephs D; Enting D; Karampera C; Khan M; Roca J; Sita-Lumsden A; Owczarczyk K; Wylie H; Haire A; Smith D; Zaki K; Swampillai A; Lei M; Manik V; Michalarea V; Kristeleit R; Mera A; Sawyer E; Flanders L; De Francesco I; Papa S; Ross P; Spicer J; Dann B; Jogia V; Shaunak N; Kristeleit H; Rigg A; Montes A; Van Hemelrijck M; Dolly S
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053432
[TBL] [Abstract][Full Text] [Related]
4. Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19.
Várnai C; Palles C; Arnold R; Curley HM; Purshouse K; Cheng VWT; Booth S; Campton NA; Collins GP; Hughes DJ; Kulasekararaj AG; Lee AJX; Olsson-Brown AC; Sharma-Oates A; Van Hemelrijck M; Lee LYW; Kerr R; Middleton G; Cazier JB;
JAMA Netw Open; 2022 Feb; 5(2):e220130. PubMed ID: 35188551
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.
Fox TA; Troy-Barnes E; Kirkwood AA; Chan WY; Day JW; Chavda SJ; Kumar EA; David K; Tomkins O; Sanchez E; Scully M; Khwaja A; Lambert J; Singer M; Roddie C; Morris EC; Yong KL; Thomson KJ; Ardeshna KM
Br J Haematol; 2020 Oct; 191(2):194-206. PubMed ID: 32678948
[TBL] [Abstract][Full Text] [Related]
6. Modification of systemic anti-cancer therapies and weight loss, a population-level real-world evidence study.
Shaw C; Starling N; Reich A; Wilkes E; White R; Shepelev J; Narduzzi S
Ther Adv Med Oncol; 2020; 12():1758835920982805. PubMed ID: 33488780
[TBL] [Abstract][Full Text] [Related]
7. Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19.
So ACP; Karampera C; Khan M; Russell B; Moss C; Monroy-Iglesias MJ; Thillai K; Josephs DH; Pintus E; Rudman S; Van Hemelrijck M; Dolly S; Enting D
BMC Urol; 2022 Apr; 22(1):71. PubMed ID: 35488333
[TBL] [Abstract][Full Text] [Related]
8. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
[TBL] [Abstract][Full Text] [Related]
9. Systemic Anti-Cancer Therapy Use in Palliative Care Outpatients With Advanced Cancer.
Wadhwa D; Hausner D; Popovic G; Pope A; Swami N; Maganti M; Zimmermann C
J Palliat Care; 2021 Apr; 36(2):78-86. PubMed ID: 33241732
[TBL] [Abstract][Full Text] [Related]
10. Systemic anti-cancer therapy patterns in advanced non-small cell lung cancer in Europe.
Hofmarcher T; Lindgren P; Wilking N
J Cancer Policy; 2022 Dec; 34():100362. PubMed ID: 36087918
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study.
Gibson AJW; Li H; D'Silva A; Elegbede AA; Tudor RA; Otsuka S; Bebb DG; Cheung WY
Lung Cancer; 2019 Aug; 134():141-146. PubMed ID: 31319972
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic.
Lee AJX; Purshouse K
Br J Cancer; 2021 May; 124(11):1777-1784. PubMed ID: 33767417
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with adjuvant systemic anti-cancer treatment discontinuation for early breast cancer during the COVID-19 pandemic.
Gatfield ER; Bataineh A; El Kurdi B; Mukesh MB; Loo SW
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13668. PubMed ID: 35950493
[TBL] [Abstract][Full Text] [Related]
14. Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected Data.
Holling N; Patole S; Medford ARL; Maskell NA; Bibby AC
Chest; 2021 Nov; 160(5):1915-1924. PubMed ID: 34023321
[TBL] [Abstract][Full Text] [Related]
15. Non-small cell lung cancer chemotherapy treatment outcomes and ethnicity: a twenty-year single-centre patterns of care study.
Nguyen H; Keenan R; Kennedy I; Lao C; Lawrenson R
N Z Med J; 2023 Nov; 136(1585):24-34. PubMed ID: 37956355
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
[TBL] [Abstract][Full Text] [Related]
17. Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.
Russell B; Moss C; Monroy-Iglesias M; Roberts G; Dickinson H; Haire K; Innes K; Mulji-Shah B; Castell F; Al-Salihi O; Lei M; Francis A; Dann B; Jogia V; Hamid H; Challacombe B; Simo R; Fraser S; Gousis C; Sawyer E; Tsotra E; Roca J; Khan M; Josephs D; Enting D; Van Hemelrijck M; Harris V; Dolly S
Br J Cancer; 2022 Oct; 127(7):1289-1295. PubMed ID: 35840733
[TBL] [Abstract][Full Text] [Related]
18. Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer.
Oselin K; Pisarev H; Ilau K; Kiivet RA
BMC Cancer; 2021 Mar; 21(1):274. PubMed ID: 33722202
[TBL] [Abstract][Full Text] [Related]
19. Mortality and morbidity of curative and palliative anticancer treatments during the COVID-19 pandemic: A multicenter population-based retrospective study.
Tashkandi E; Al-Abdulwahab A; Basulaiman B; Alsharm A; Al-Hajeili M; Alshadadi F; Halawani L; Al-Mansour M; Alquzi B; Barnawi S; Alghamdi M; Abdelaziz N; Azher R
Mol Clin Oncol; 2021 Apr; 14(4):82. PubMed ID: 33758663
[TBL] [Abstract][Full Text] [Related]
20. Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England.
Gannon MR; Park MH; Miller K; Dodwell D; Horgan K; Clements K; Medina J; Cromwell DA
Cancer Epidemiol; 2023 Apr; 83():102337. PubMed ID: 36774694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
